{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:54:12Z","timestamp":1787014452799,"version":"build-2736575974"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2012,8,2]],"date-time":"2012-08-02T00:00:00Z","timestamp":1343865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,8,2]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>Serum levels and liver expression of CCL2 are increased in patients with alcoholic hepatitis (AH). In an experimental model of alcoholic liver disease (ALD), CCL2 was implicated in proinflammatory cytokines activation and hepatic lipid metabolism, but its role in human disease is currently unknown. In a large cohort of ALD patients, we analysed plasma levels and liver expression of CCL2 and their association with liver disease severity and histological lesions. We also studied the relationship between \u22122518 A\u2003&amp;gt;\u2003G CCL2 and CCR2 190 A\/G polymorphisms and severity of ALD. We show that CCL2 plasma levels are increased in ALD patients compared with healthy subjects. AH patients had significantly higher plasma levels and hepatic expression of CCL2 than patients without AH. Plasma levels and hepatic expression of CCL2 were associated with disease severity. CCL2 liver expression was correlated with neutrophil infiltrate and interleukin (IL)-8 expression, but not with steatosis. Moreover, there were more G-allele carriers of \u22122518 A\u2003&amp;gt;\u2003G CCL2 polymorphism in severe AH patients than in other ALD patients. Our results demonstrate that CCL2 is increased in ALD, particularly in severe forms, and suggest a role for CCL2 in the pathogenesis of ALD via neutrophil recruitment.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2012.04609.x","type":"journal-article","created":{"date-parts":[[2012,5,7]],"date-time":"2012-05-07T04:25:51Z","timestamp":1336364751000},"page":"302-310","source":"Crossref","is-referenced-by-count":58,"title":["Hepatic expression of CCL2 in alcoholic liver disease is associated with disease severity and neutrophil infiltrates"],"prefix":"10.1093","volume":"169","author":[{"given":"D","family":"Degr\u00e9","sequence":"first","affiliation":[{"name":"Laboratory of Experimental Gastroenterology"},{"name":"Department of Gastroenterology, Hepatopancreatology and Digestive Oncology, Erasme Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Lemmers","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Gastroenterology"},{"name":"Department of Gastroenterology, Hepatopancreatology and Digestive Oncology, Erasme Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Gustot","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Gastroenterology"},{"name":"Department of Gastroenterology, Hepatopancreatology and Digestive Oncology, Erasme Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Ouziel","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Gastroenterology"},{"name":"Department of Gastroenterology, Hepatopancreatology and Digestive Oncology, Erasme Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Tr\u00e9po","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Gastroenterology"},{"name":"Department of Gastroenterology, Hepatopancreatology and Digestive Oncology, Erasme Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Demetter","sequence":"additional","affiliation":[{"name":"Department of Pathology, Erasme Hospital. Universit\u00e9 Libre de Bruxelles (ULB), Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Verset","sequence":"additional","affiliation":[{"name":"Department of Pathology, Erasme Hospital. Universit\u00e9 Libre de Bruxelles (ULB), Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Quertinmont","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Gastroenterology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Vercruysse","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Gastroenterology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Le Moine","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Gastroenterology"},{"name":"Department of Gastroenterology, Hepatopancreatology and Digestive Oncology, Erasme Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Devi\u00e8re","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Gastroenterology"},{"name":"Department of Gastroenterology, Hepatopancreatology and Digestive Oncology, Erasme Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Moreno","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Gastroenterology"},{"name":"Department of Gastroenterology, Hepatopancreatology and Digestive Oncology, Erasme Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,8,2]]},"reference":[{"key":"2021122708375804700_b1","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/ncpgasthep0683","article-title":"Management strategies in alcoholic liver disease","volume":"4","author":"Tilg","year":"2007","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"2021122708375804700_b2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1055\/s-2008-1040605","article-title":"Histologic spectrum of alcoholic liver disease","volume":"6","author":"MacSween","year":"1986","journal-title":"Semin Liver Dis"},{"key":"2021122708375804700_b3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/gut.2010.224097","article-title":"Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data","volume":"60","author":"Mathurin","year":"2011","journal-title":"Gut"},{"key":"2021122708375804700_b4","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/j.1365-2036.2007.03302.x","article-title":"Fibrosis progression occurs in a subgroup of heavy drinkers with typical histological features","volume":"25","author":"Mathurin","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"2021122708375804700_b5","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/hep.1840090302","article-title":"Increased tumor necrosis factor production by monocytes in alcoholic hepatitis","volume":"9","author":"McClain","year":"1989","journal-title":"Hepatology"},{"key":"2021122708375804700_b6","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/hep.1840110416","article-title":"Excessive in vitro bacterial lipopolisaccharide-induced production of monokines in cirrhosis","volume":"11","author":"Devi\u00e8re","year":"1990","journal-title":"Hepatology"},{"key":"2021122708375804700_b7","first-page":"221","article-title":"High interleukin-6 serum levels and increased production by leucocytes in alcoholic liver cirrhosis: correlation with IgA serum levels and lymphokines production","volume":"77","author":"Devi\u00e8re","year":"1989","journal-title":"Clin Exp Immunol"},{"key":"2021122708375804700_b8","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1053\/j.gastro.2009.01.056","article-title":"Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis","volume":"136","author":"Dominguez","year":"2009","journal-title":"Gastroenterology"},{"key":"2021122708375804700_b9","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/(SICI)1096-9896(199809)186:1<82::AID-PATH151>3.0.CO;2-D","article-title":"Distinct patterns of chemokine expression are associated with leukocyte recruitment in alcoholic hepatitis and alcoholic cirrhosis","volume":"186","author":"Afford","year":"1998","journal-title":"J Pathol"},{"key":"2021122708375804700_b10","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/hep.510290107","article-title":"Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells","volume":"29","author":"Marra","year":"1999","journal-title":"Hepatology"},{"key":"2021122708375804700_b11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1042\/CS20020137","article-title":"Chemokines in the pathogenesis of liver disease: so many players with poor defined roles","volume":"104","author":"Simpson","year":"2003","journal-title":"Clin Sci"},{"key":"2021122708375804700_b12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1034\/j.1600-065X.2000.17703.x","article-title":"The role of chemokines in the immunopathology of the liver","volume":"177","author":"Bone-Larson","year":"2000","journal-title":"Immunol Rev"},{"key":"2021122708375804700_b13","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1053\/j.gastro.2006.12.036","article-title":"Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlation with disease severity","volume":"132","author":"Colmenero","year":"2007","journal-title":"Gastroenterology"},{"key":"2021122708375804700_b14","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1136\/gut.45.3.416","article-title":"Serum concentrations and peripheral secretion of the beta chemokines monocyte chemoattractant protein 1 and macrophage inflammatory protein 1 alpha in alcoholic liver disease","volume":"45","author":"Fischer","year":"1999","journal-title":"Gut"},{"key":"2021122708375804700_b15","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1006\/cyto.1999.0495","article-title":"Increased monocyte MCP-1 production in acute alcoholic hepatitis","volume":"11","author":"Devalaraja","year":"1999","journal-title":"Cytokine"},{"key":"2021122708375804700_b16","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1002\/hep.24599","article-title":"An essential role for MCP-1 in alcoholic liver injury: regulation of pro-inflammatory cytokines and hepatic steatosis","volume":"54","author":"Mandrekar","year":"2011","journal-title":"Hepatology"},{"key":"2021122708375804700_b17","first-page":"707","article-title":"Alcoholic liver disease: morphological manifestations. Review by an international group","volume":"1","year":"1981","journal-title":"Lancet"},{"key":"2021122708375804700_b18","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1055\/s-2007-1007350","article-title":"Treatment of alcoholic liver disease","volume":"13","author":"Mezey","year":"1993","journal-title":"Semin Liver Dis"},{"key":"2021122708375804700_b19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0022-1759(01)00489-6","article-title":"Cytokine mRNA quantification by real-time PCR","volume":"259","author":"Stordeur","year":"2002","journal-title":"J Immunol Methods"},{"key":"2021122708375804700_b20","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/hep.22680","article-title":"The interleukin-17 pathway is involved in human alcoholic liver disease","volume":"49","author":"Lemmers","year":"2009","journal-title":"Hepatology"},{"key":"2021122708375804700_b21","volume-title":"Molecular cloning: a laboratory manual","author":"Sambrook","year":"1989","edition":"2nd"},{"key":"2021122708375804700_b22","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1182\/blood-2009-04-216085","article-title":"Evidence of a cross-talk between human neutrophils and Th17 cells","volume":"115","author":"Pelletier","year":"2010","journal-title":"Blood"},{"key":"2021122708375804700_b23","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1006\/bbrc.1999.0796","article-title":"A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression","volume":"259","author":"Rovin","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"2021122708375804700_b24","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0016-5085(03)01213-7","article-title":"A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease","volume":"125","author":"Muhlbauer","year":"2003","journal-title":"Gastroenterology"},{"key":"2021122708375804700_b25","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00384-003-0477-0","article-title":"Polymorphism of monocyte chemoattractant protein 1 in Crohn's disease","volume":"18","author":"Herfarth","year":"2003","journal-title":"Int J Colorect Dis"},{"key":"2021122708375804700_b26","doi-asserted-by":"crossref","first-page":"8053","DOI":"10.4049\/jimmunol.181.11.8053","article-title":"Infiltrated neutrophils acquire novel chemokine receptor expression and chemokine responsiveness in chronic inflammatory lung diseases","volume":"181","author":"Hartl","year":"2008","journal-title":"J Immunol"},{"key":"2021122708375804700_b27","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1164\/rccm.201003-0416OC","article-title":"Essential role of CCR2 in neutrophil tissue infiltration and multiple organ dysfunction in sepsis","volume":"183","author":"Souto","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2021122708375804700_b28","doi-asserted-by":"crossref","first-page":"5558","DOI":"10.3748\/wjg.15.5558","article-title":"Analysis of monocyte chemotactic protein-1 gene polymorphism in patients with spontaneous bacterial peritonitis","volume":"15","author":"Gabele","year":"2009","journal-title":"World J Gastroenterol"},{"key":"2021122708375804700_b29","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1542-3565(05)00163-1","article-title":"Is the monocyte chemotactic protein-1 -2518 G allele a risk factor for severe acute pancreatitis","volume":"3","author":"Papachristou","year":"2005","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2012.04609.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/169\/3\/302\/41907752\/j.1365-2249.2012.04609.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/169\/3\/302\/41907752\/j.1365-2249.2012.04609.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T11:18:54Z","timestamp":1641035934000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/169\/3\/302\/6438592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,2]]},"references-count":29,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2012,8,2]]},"published-print":{"date-parts":[[2012,8,2]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2012.04609.x","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,9]]},"published":{"date-parts":[[2012,8,2]]}}}